Table 4

PFS (progression free survival) according toKRASmutation for the two different treatment arms
PFS FUFOX CAPOX p-value (log rank)
n = 105 n = 96 HR (95% CI)
All patients 8.2 months 6.4 months

0.18

0.81 (0.61-1.09)

WT 8.1months 6.4months 0.29
0.82 (0.56-1.19)
Codon 12 mutation 9.9months 7.0months 0.12
0.62 (0.33-1.14)
Codon 13 mutation 6.1months 13.3months 0.22
2.52 (0.54-11.70)

PFS, HR hazard ratio by cox regression, CI confidence interval, WT wild type.

Reinacher-Schick et al.

Reinacher-Schick et al. BMC Cancer 2012 12:349   doi:10.1186/1471-2407-12-349

Open Data